Results 81 to 90 of about 6,458 (228)
Majalah Kardiologi Indonesia, 2015 Background: Eptifibatide, an inhibitor of glycoprotein IIb/IIIa administered as adjunctive therapy to reperfusion therapy Primary PCI in STEMI patients.
Elisa Feriyanti Pakpahan +2 more
doaj +1 more source
A critical review of therapeutic interventions in sickle cell disease: Progress and challenges
Archiv der Pharmazie, Volume 357, Issue 11, November 2024.Sickle cell disease reflects a complex interplay of genetics, hematology, and clinical symptoms. The intricate pathogenesis of the disease offers a landscape with various targets and treatment options. Anticipated advancements in treatment include combining fetal hemoglobin inducers with other drug classes to improve the efficacy beyond monotherapy ...
Chandu Ala +6 more
wiley +1 more source
Journal of Peptide Science, Volume 30, Issue 11, November 2024.This review provides an overview of FDA‐approved peptides, particularly those targeting cardiovascular diseases, human immunodeficiency, and central nervous system diseases, and also addresses conditions such as osteoporosis, thrombocytopenia, Cushing's disease, and hypoglycemia.
Othman Al Musaimi
wiley +1 more source
Scientific Reports, 2021 A novel specific spin-labeling strategy for bioactive molecules is presented for eptifibatide (integrilin) an antiplatelet aggregation inhibitor, which derives from the venom of certain rattlesnakes.
Kevin Herr +8 more
doaj +1 more source
Pharmacotherapy of Acute Coronary Syndromes: Medical Economics with an Emphasis on Clopidogrel [PDF]
, 2018 Summary: Acute coronary syndromes account worldwide for a significant burden of hospital- and societal costs. Pharmacotherapy of acute coronary syndromes consists of a combined antithrombotic therapy.
Bramkamp, Matthias +2 more
core
The chaperone protein HSP47: a platelet collagen binding protein that contributes to thrombosis and haemostasis [PDF]
, 2018 Objective: Heat shock protein 47 (HSP47) is an intracellular chaperone protein that is vital for collagen biosynthesis in collagen secreting cells. This protein has also been shown to be present on the surface of platelets.
AlOuda, K. S. +11 more
core +2 more sources
Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Therapeutics and Clinical Risk Management, 2014 Pasala T, Sattayaprasert P, Bhat PK, Athappan G, Gandhi S. Ther Clin Risk Manag. 2014;10:603–614.The TIMI abbreviation definition of “thrombosis in myocardial infarction” is incorrect for Table 2 on page 606 and Table 3 on page 607. It should read “thrombolysis in myocardial infarction”.Read the original article
Ganesh Athappan +4 more
openaire +5 more sources
Therapeutic Plasma Exchange to Reverse Plasma Failure in Multiple Organ Dysfunction Syndrome
Journal of Clinical Apheresis, Volume 39, Issue 5, October 2024.ABSTRACT Plasma plays a crucial role in maintaining health through regulating coagulation and inflammation. Both are essential to respond to homeostatic threats such as traumatic injury or microbial infection; however, left unchecked, they can themselves cause damage.
Matthew J. Foglia +3 more
wiley +1 more source
Journal of Tehran University Heart Center, 2015 Background: Administration of glycoprotein IIb/IIIa inhibitors is an effective adjunctive treatment strategy during primary percutaneous coronary intervention (PPCI) for ST-segment elevation myocardial infarction (STEMI).
MohammadHasan Namazi +5 more
doaj
Ultrasound enhanced prehospital thrombolysis using microbubbles infusion in patients with acute ST elevation myocardial infarction: Rationale and design of the Sonolysis study [PDF]
, 2008 Contains fulltext : 70525.pdf (publisher's version ) (Open Access)ABSTRACT: BACKGROUND -: Experimental studies have shown that ultrasound contrast agents enhance the effectiveness of thrombolytic agents in the presence of ultrasound in ...
A van Wamel +30 more
core +6 more sources